quinacrine has been researched along with halothane in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Fletcher, JE; Huggins, FJ; Rosenberg, H | 1 |
Fletcher, JE; Kistler, P; Michaux, K; Rosenberg, H | 1 |
Fletcher, JE; Rosenberg, H | 2 |
Genade, S; Lochner, A; Theron, S; Trollip, G; Tromp, E | 1 |
Karamanakos, PN | 1 |
9 other study(ies) available for quinacrine and halothane
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
The importance of calcium ions for in vitro malignant hyperthermia testing.
Topics: Caffeine; Calcium; Contracture; Drug Interactions; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Quinacrine; Strontium; Succinylcholine; Verapamil | 1990 |
Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
Topics: Bee Venoms; Dantrolene; Dose-Response Relationship, Drug; Halothane; Hemolysis; Humans; Hydrolysis; Phospholipases; Phospholipases A; Phospholipases A2; Phospholipids; Quinacrine | 1987 |
In vitro muscle contractures induced by halothane and suxamethonium. I: The rat diaphragm.
Topics: Animals; Dantrolene; Diaphragm; Drug Synergism; Halothane; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Quinacrine; Rats; Rats, Inbred Strains; Spermine; Succinylcholine; Tubocurarine | 1986 |
In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Fatty Acids, Nonesterified; Halothane; Humans; In Vitro Techniques; Indomethacin; Malignant Hyperthermia; Muscle Contraction; Muscles; Phospholipases A; Phospholipases A2; Quinacrine; Spermine; Succinylcholine | 1986 |
Postcardioplegic myocardial recovery: effects of halothane, nifedipine, HOE 694, and quinacrine.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Halothane; Heart Arrest, Induced; Male; Myocardial Reperfusion Injury; Nifedipine; Quinacrine; Rats; Rats, Wistar; Sulfones | 1998 |
Could quinacrine prevent 'halothane hepatitis'?
Topics: Anesthetics, Inhalation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1 Inhibitors; Halothane; Humans; Quinacrine | 2009 |